Medicine and Dentistry
Endoscopic Surgery
100%
Neoplasm
81%
Endoscopy
73%
functional dyspepsia
73%
Colonoscopy
71%
Endoscopic Submucosal Dissection
70%
Lymph Node Metastasis
64%
Prevalence
51%
Colitis
50%
Reflux Esophagitis
47%
Helicobacter Pylori
46%
Adenoma
44%
Overall Survival
44%
Gastrointestinal Endoscopy
40%
Meta-Analysis
40%
Patient Referral
40%
Gastrointestinal Bleeding
40%
Antithrombotic Agent
40%
Recurrent Disease
39%
Odds Ratio
36%
Colorectal Carcinoma
35%
Hazard Ratio
34%
Computer Assisted Tomography
34%
Gastrectomy
32%
Upper Digestive Tract
32%
Endoscopic Ultrasound
31%
Upper Gastrointestinal Bleeding
30%
Adiponectin
30%
Tonsil
30%
Mesenchymal Stem Cell
30%
Biopsy Technique
30%
Survival Rate
29%
Squamous Cell Carcinoma
26%
Combination Therapy
25%
Fluorodeoxyglucose F 18
23%
Fluorodeoxyglucose
23%
Esophagus
23%
Colon
22%
Polypectomy
22%
Cohort Analysis
22%
Dextran Sulfate
20%
Distant Metastasis
20%
Bisacodyl
20%
Ascorbic Acid
20%
Peptoclostridium difficile
20%
Antiphospholipid Syndrome
20%
Embolization
20%
Intestine Preparation
20%
Clinical Study
20%
Ingestion
20%
Pharmacology, Toxicology and Pharmaceutical Science
Stomach Acid
53%
Helicobacter Pylori
44%
Combination Therapy
33%
Colitis
30%
Adiponectin
30%
Reflux Esophagitis
24%
Adenoma
23%
Neoplasm
23%
Inflammatory Bowel Disease
22%
Calcium Sensing Receptor
20%
Macrogol
20%
Caustic Agent
20%
Controlled Release
20%
Dextran Sulfate
20%
Prevalence
20%
Ascorbic Acid
20%
Nausea
20%
Nortriptyline
20%
Placebo
20%
Epstein Barr Virus Infection
20%
Lymphoepithelioma
20%
Clinical Study
20%
Stomach Carcinoma
20%
Bisacodyl
20%
Antibiotics
20%
Clinical Feature
20%
Gastric Lavage
20%
Colorectal Carcinoma
13%
Comorbidity
13%
Proton Pump Inhibitor
12%
Carcinogenesis
12%
Messenger RNA
11%
Survival Rate
11%
Anticoagulant Agent
10%
Clarithromycin
10%
Adenocarcinoma
10%
Postoperative Complication
10%
Paradoxical Reaction
10%
Midazolam
10%
Flumazenil
10%
Gastrointestinal Hemorrhage
10%
Survival Time
10%
Tegoprazan
10%
Helicobacter Infection
10%
Ghrelin
10%
Rituximab
10%
Follicular Lymphoma
10%
Prospective Study
8%
Antivitamin K
6%
Cytokine
6%